Bill > H5173

This bill requires health insurance plans in Rhode Island that provide prescription drug coverage to cover at least one type of glucagon medication for treating hypoglycemia (low blood sugar), starting January 1, 2026. Specifically, the bill mandates that health insurers cover glucagon in forms such as auto-injectors, nasal sprays, or formulations that do not require reconstitution, with no copayments or deductibles for patients. The legislation applies to various types of health insurance plans, including individual and group contracts, nonprofit hospital and medical service corporations, and health maintenance organizations. The bill recognizes that glucagon is a life-saving medication often used in emergency situations by non-medical professionals to help people with diabetes who are experiencing dangerously low blood sugar levels. While most plans would be required to implement this coverage starting in 2026, the bill allows insurers to adopt these benefits earlier. An exception is made for health savings account-qualified plans, which may still apply deductibles. The bill aims to improve diabetes management by reducing barriers to accessing critical emergency medication and potentially lowering overall healthcare costs associated with untreated hypoglycemia.

Health and Social Services

https://status.rilegislature.gov/